• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

莫尔基奥综合征A的自然病史:一名气管梗阻患者从出生到死亡的情况。

Natural history of Morquio A patient with tracheal obstruction from birth to death.

作者信息

Doherty Caitlin, Averill Lauren W, Theroux Mary, Mackenzie William G, Pizarro Christian, Mason Robert W, Tomatsu Shunji

机构信息

Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE, USA.

University of Delaware, Newark, DE, USA.

出版信息

Mol Genet Metab Rep. 2017 Dec 22;14:59-67. doi: 10.1016/j.ymgmr.2017.11.005. eCollection 2018 Mar.

DOI:10.1016/j.ymgmr.2017.11.005
PMID:29326877
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5758848/
Abstract

Morquio A syndrome (mucopolysaccharidosis IVA, MPS IVA) is a lysosomal storage disease caused by a deficiency of -acetylgalactosamine-6-sulfate sulfatase, resulting in systemic accumulation of the partially degraded glycosaminoglycans (GAGs), keratan sulfate and chondroitin-6-sulfate. The accumulation of these GAGs leads to distinguishing features as skeletal dysplasia with disproportionate dwarfism, short neck, kyphoscoliosis, pectus carinatum, tracheal obstruction, coxa valga, genu valgum, and joint laxity. In the absence of autopsied cases and systemic analysis of multiple tissues, the pathological mechanism of the characteristic skeletal dysplasia associated with the disease largely remains a question. Here we report an autopsied case of a 23-year-old male with MPS IVA, who developed characteristic skeletal abnormalities by 4 months of age and died of severe tracheal obstruction and hypoventilation originating from respiratory muscle weakness from neurological cord deficit due to cord myelopathy at the age of 23. We analyzed postmortem tissues pathohistologically, including the thyroid, lung, lung bronchus, trachea, heart, aorta, liver, spleen, kidney, testes, humerus, knee cartilage, and knee ligament. Examination of the tissues demonstrated systemic storage materials in multiple tissues, as well as severely ballooned and vacuolated chondrocytes in the trachea, humerus, knee cartilage, and lung bronchus. This autopsied case with MPS IVA addresses the importance of tracheal obstruction for morbidity and mortality of the disease, and the pathological findings contribute to a further understanding of the pathogenesis of MPS IVA and the development of novel therapies.

摘要

莫尔基奥A综合征(黏多糖贮积症IVA型,MPS IVA)是一种溶酶体贮积病,由N - 乙酰半乳糖胺 - 6 - 硫酸酯酶缺乏引起,导致部分降解的糖胺聚糖(GAGs)、硫酸角质素和硫酸软骨素 - 6在全身蓄积。这些GAGs的蓄积导致了一些显著特征,如骨骼发育异常伴不成比例的侏儒症、短颈、脊柱后凸侧弯、鸡胸、气管阻塞、髋外翻、膝外翻和关节松弛。由于缺乏尸检病例以及对多个组织的系统分析,与该疾病相关的特征性骨骼发育异常的病理机制在很大程度上仍是一个疑问。在此,我们报告一例23岁男性MPS IVA的尸检病例,该患者在4个月大时出现特征性骨骼异常,并于23岁时死于严重气管阻塞和呼吸肌无力导致的通气不足,呼吸肌无力源于脊髓病引起的神经脊髓缺陷。我们对死后组织进行了病理组织学分析,包括甲状腺、肺、肺支气管、气管、心脏、主动脉、肝脏、脾脏、肾脏、睾丸、肱骨、膝关节软骨和膝关节韧带。组织检查显示多个组织中有全身贮积物质,以及气管、肱骨、膝关节软骨和肺支气管中严重肿胀和空泡化的软骨细胞。这例MPS IVA尸检病例揭示了气管阻塞对该疾病发病率和死亡率的重要性,病理结果有助于进一步理解MPS IVA的发病机制以及开发新的治疗方法。

相似文献

1
Natural history of Morquio A patient with tracheal obstruction from birth to death.莫尔基奥综合征A的自然病史:一名气管梗阻患者从出生到死亡的情况。
Mol Genet Metab Rep. 2017 Dec 22;14:59-67. doi: 10.1016/j.ymgmr.2017.11.005. eCollection 2018 Mar.
2
Pathogenesis of Morquio A syndrome: an autopsied case reveals systemic storage disorder.黏多糖贮积症 A 型的发病机制:尸检病例揭示全身性贮积紊乱。
Mol Genet Metab. 2013 Jul;109(3):301-11. doi: 10.1016/j.ymgme.2013.04.009. Epub 2013 Apr 16.
3
Mucopolysaccharidosis IVA and glycosaminoglycans.IVA型黏多糖贮积症与糖胺聚糖
Mol Genet Metab. 2017 Jan-Feb;120(1-2):78-95. doi: 10.1016/j.ymgme.2016.11.007. Epub 2016 Nov 29.
4
Molecular genetics and metabolism, special edition: Diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA.分子遗传学与新陈代谢特刊:黏多糖贮积症 IVA 的诊断、诊断和预后。
Mol Genet Metab. 2018 Sep;125(1-2):18-37. doi: 10.1016/j.ymgme.2018.05.004. Epub 2018 May 15.
5
Therapies of mucopolysaccharidosis IVA (Morquio A syndrome).黏多糖贮积症IVA型(莫尔基奥A综合征)的治疗方法。
Expert Opin Orphan Drugs. 2013 Oct 1;1(10):805-818. doi: 10.1517/21678707.2013.846853.
6
Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment.黏多糖贮积症 IVA 型(莫尔奎奥 A 病):临床综述与当前治疗。
Curr Pharm Biotechnol. 2011 Jun;12(6):931-45. doi: 10.2174/138920111795542615.
7
Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management.黏多糖贮积症 IVA:诊断、治疗与管理。
Int J Mol Sci. 2020 Feb 23;21(4):1517. doi: 10.3390/ijms21041517.
8
Bone Growth Induction in Mucopolysaccharidosis IVA Mouse.MPSIVA 小鼠的骨生长诱导
Int J Mol Sci. 2023 Jun 8;24(12):9890. doi: 10.3390/ijms24129890.
9
Current and emerging treatments and surgical interventions for Morquio A syndrome: a review.莫尔基奥A综合征的现有及新出现的治疗方法和外科干预措施:综述
Res Rep Endocr Disord. 2012 Dec;2012(2):65-77. doi: 10.2147/RRED.S37278.
10
A pictorial review of the radiographic skeletal findings in Morquio syndrome (mucopolysaccharidosis type IV).穆-柯二氏综合征(黏多糖贮积症 IV 型)的骨骼放射影像学表现图谱。
Pediatr Radiol. 2023 May;53(5):971-983. doi: 10.1007/s00247-022-05585-3. Epub 2023 Jan 11.

引用本文的文献

1
Novel approach for tracheal resection in Morquio a syndrome with end-stage critical airway obstruction: a UK case series.新型方法用于治疗黏多糖贮积症 A 型终末期严重气道阻塞的气管切除术:英国病例系列。
Orphanet J Rare Dis. 2024 Jul 22;19(1):274. doi: 10.1186/s13023-024-03253-3.
2
Molecular therapy and nucleic acid adeno-associated virus-based gene therapy delivering combinations of two growth-associated genes to MPS IVA mice.分子疗法以及基于腺相关病毒的核酸基因疗法,将两种生长相关基因组合传递给黏多糖贮积症IVA型小鼠。
Mol Ther Nucleic Acids. 2024 May 7;35(2):102211. doi: 10.1016/j.omtn.2024.102211. eCollection 2024 Jun 11.
3

本文引用的文献

1
Non-invasive pulmonary function test on Morquio patients.对黏多糖贮积症IV型患者进行的无创肺功能测试。
J Rare Dis Res Treat. 2017;2(2):55-62.
2
Current therapies for Morquio A syndrome and their clinical outcomes.目前治疗莫尔基奥A综合征的疗法及其临床疗效。
Expert Opin Orphan Drugs. 2016;4(9):941-951. doi: 10.1080/21678707.2016.1214572. Epub 2016 Jul 28.
3
Mucopolysaccharidosis IVA and glycosaminoglycans.IVA型黏多糖贮积症与糖胺聚糖
Tracheal Narrowing and Its Impact on Anesthesia Care in Patients With Morquio A (Mucopolysaccharidosis Type IVA): An Observational Study.
黏多糖贮积症 IVA 型(Mucopolysaccharidosis Type IVA,MPS IVA)患者气管狭窄及其对麻醉护理的影响:一项观察性研究。
Anesth Analg. 2023 Nov 1;137(5):1075-1083. doi: 10.1213/ANE.0000000000006513. Epub 2023 May 9.
4
Comparison of growth dynamics in different types of MPS: an attempt to explain the causes.不同类型 MPS 生长动态的比较:原因初探。
Orphanet J Rare Dis. 2022 Sep 5;17(1):339. doi: 10.1186/s13023-022-02486-4.
5
Activity of daily living in mucopolysaccharidosis IVA patients: Evaluation of therapeutic efficacy.黏多糖贮积症 IVA 患者的日常生活活动能力:疗效评估。
Mol Genet Genomic Med. 2021 Nov;9(11):e1806. doi: 10.1002/mgg3.1806. Epub 2021 Oct 8.
6
Tracheal narrowing in children and adults with mucopolysaccharidosis type IVA: evaluation with computed tomography angiography.儿童和成人黏多糖贮积症 IVA 型的气管狭窄:CT 血管造影评估。
Pediatr Radiol. 2021 Jun;51(7):1202-1213. doi: 10.1007/s00247-020-04946-0. Epub 2021 Feb 20.
7
Morquio Syndrome Presenting with Dural Band Pathology: A Case Report.以硬脊膜束带病变为表现的黏多糖贮积症IV型:一例报告
J Lab Physicians. 2020 Dec;12(4):285-288. doi: 10.1055/s-0040-1722548. Epub 2020 Dec 30.
8
Modeling Morquio A Syndrome: An Anthropometric Study of Body Characteristics and Stature.黏多糖贮积症IVA型综合征建模:身体特征和身高的人体测量学研究
Diagnostics (Basel). 2020 Feb 20;10(2):116. doi: 10.3390/diagnostics10020116.
9
Morquio-B disease: Clinical and genetic characteristics of a distinct -related dysostosis multiplex.黏多糖贮积症Ⅳ型B型:一种独特相关的多发性骨发育异常的临床和遗传特征
JIMD Rep. 2019 Nov 28;51(1):30-44. doi: 10.1002/jmd2.12065. eCollection 2020 Jan.
10
A Case Report of a Japanese Boy with Morquio A Syndrome: Effects of Enzyme Replacement Therapy Initiated at the Age of 24 Months.一个日本莫尔奎奥 A 综合征男孩的病例报告:24 个月时开始酶替代治疗的效果。
Int J Mol Sci. 2020 Feb 2;21(3):989. doi: 10.3390/ijms21030989.
Mol Genet Metab. 2017 Jan-Feb;120(1-2):78-95. doi: 10.1016/j.ymgme.2016.11.007. Epub 2016 Nov 29.
4
Surgical Reconstruction for Severe Tracheal Obstruction in Morquio A Syndrome.黏多糖贮积症IVA型综合征严重气管梗阻的外科重建术
Ann Thorac Surg. 2016 Oct;102(4):e329-31. doi: 10.1016/j.athoracsur.2016.02.113.
5
Obstructive airway in Morquio A syndrome, the past, the present and the future.黏多糖贮积症IVA型中的气道阻塞:过去、现在与未来
Mol Genet Metab. 2016 Feb;117(2):150-6. doi: 10.1016/j.ymgme.2015.09.007. Epub 2015 Sep 21.
6
Current and emerging treatments and surgical interventions for Morquio A syndrome: a review.莫尔基奥A综合征的现有及新出现的治疗方法和外科干预措施:综述
Res Rep Endocr Disord. 2012 Dec;2012(2):65-77. doi: 10.2147/RRED.S37278.
7
Mortality in patients with morquio syndrome a.黏多糖贮积症IV型A患者的死亡率
JIMD Rep. 2015;15:59-66. doi: 10.1007/8904_2014_298. Epub 2014 Apr 10.
8
Pathogenesis of Morquio A syndrome: an autopsied case reveals systemic storage disorder.黏多糖贮积症 A 型的发病机制:尸检病例揭示全身性贮积紊乱。
Mol Genet Metab. 2013 Jul;109(3):301-11. doi: 10.1016/j.ymgme.2013.04.009. Epub 2013 Apr 16.
9
Anesthetic care and perioperative complications of children with Morquio syndrome.黏多糖贮积症IV型患儿的麻醉护理及围手术期并发症
Paediatr Anaesth. 2012 Sep;22(9):901-7. doi: 10.1111/j.1460-9592.2012.03904.x. Epub 2012 Jun 27.
10
Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment.黏多糖贮积症 IVA 型(莫尔奎奥 A 病):临床综述与当前治疗。
Curr Pharm Biotechnol. 2011 Jun;12(6):931-45. doi: 10.2174/138920111795542615.